Reach Us +44-1647-403003
Importance Of A Multidisciplinary Approach To Breast Cancer Treatment In Pregnancy: Case Report Of New Diagnosis Of Pregnancy-associated Breast Cancer | 53009
ISSN: 1948-5956

Journal of Cancer Science & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Importance of a multidisciplinary approach to breast cancer treatment in pregnancy: Case report of new diagnosis of pregnancy-associated breast cancer

2nd World Congress on Breast Cancer

Jeremy Grant and Jessica Hoyson

Western Pennsylvania Hospital, USA

Posters & Accepted Abstracts: J Cancer Sci Ther

DOI: 10.4172/1948-5956.C1.082

Pregnancy-Associated Breast Cancer (PBAC) is a rare diagnosis and includes new diagnoses of cancer both during pregnancy as well as within the first year post-delivery. Due to its rarity, there is of yet no gold standard treatment nor is there sufficient scientific data to support a standardized regimen. We report a case involving a 35-year-old G2P1001 who was diagnosed with clinical stage II (T2 N1) breast cancer in the second trimester of pregnancy after physical examination revealed a palpable mass. Ultrasound-guided biopsy revealed poorly differentiated infiltrating ductal carcinoma, nuclear grade 3, with micropapillary features, ER (90%), PR (25%), positive HER2 positive 3+ with Ki67 index 75%. After extensive counseling and discussion between Obstetrics, Maternal Fetal Medicine, Breast Surgery, Neonatal ICU, and Oncology, a decision was made to initiate neoadjuvant therapy with Adriamycin and cyclophosphamide. She completed 4 total NAC treatments prior to delivery then began weekly Taxol plus Herceptin and Perjeta following delivery. This patient strongly desired to carry the pregnancy to term and began treatment prior to delivery, making this case unique in comparison to other publications in which treatment was delayed until after delivery, or the pregnancy was terminated prior to beginning treatment. Our case highlights the importance of a multi-disciplinary approach to counseling these patients as there remains no gold standard of care at this time.

Jeremy Grant completed his MD at Temple University School of Medicine in Philadelphia, Pennsylvania. He is a third-year resident in Obstetrics & Gynecology at Western Pennsylvania Hospital.

Jessica Hoyson completed her MD at Rush University in Chicago, Illinois, and her residency at MetroHealth/Cleveland Clinic in Ohio. She has published several articles in reputable journals on gynecologic malignancies, minimally invasive surgery, and ethics, a textbook chapter on single-site laparoscopy, and presented a surgical film at the national meeting for the Society of Gynecologic Oncology. She is currently on staff at the Western Pennsylvania Hospital in the department of Obstetrics &

Email: Gynecology. [email protected] [email protected]

Relevant Topics